相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current status of theranostics in prostate cancer
Irene Virgolini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health
Clement K. Ho et al.
ACTA ONCOLOGICA (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity
Huijuan Zhu et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer
A. Y. Zhang et al.
ANNALS OF ONCOLOGY (2017)
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers
Christoph Burdelski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles
Anthony Mathelier et al.
NUCLEIC ACIDS RESEARCH (2016)
miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4
Jia-Jun Cai et al.
ONCOLOGY REPORTS (2016)
AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ-ERK2 pathways
Ming-Yi Xu et al.
CANCER LETTERS (2016)
Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
Jingwen Zhao et al.
ONCOTARGET (2016)
Androgens Regulate SMAD Ubiquitination Regulatory Factor-1 Expression and Prostate Cancer Cell Invasion
Xiaokun Gang et al.
PROSTATE (2015)
Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast
Seow Foong Loh et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression
Ken-ichi Takayama et al.
CANCER RESEARCH (2014)
Prostate cancer in young men: an important clinical entity
Claudia A. Salinas et al.
NATURE REVIEWS UROLOGY (2014)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer
Nima Sharifi
MOLECULAR ENDOCRINOLOGY (2013)
Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms
Laetitia Delort et al.
ONCOLOGY REPORTS (2013)
Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer
Wenjuan Mo et al.
PLOS ONE (2013)
The Kinetics of G2 and M Transitions Regulated by B Cyclins
Yehong Huang et al.
PLOS ONE (2013)
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants
Laura R. Bohrer et al.
PROSTATE (2013)
Androgen action and metabolism in prostate cancer
Sean M. Green et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
Renee C. Prins et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Blockade of testicular and adrenal androgens in prostate cancer treatment
Fernand Labrie
NATURE REVIEWS UROLOGY (2011)
Structure-Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
Michael E. Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Both in Vitro and in Vivo
Takashi Kobayashi et al.
MOLECULAR ENDOCRINOLOGY (2010)
AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
B. Kong et al.
ONCOGENE (2010)
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
X. N. Meng et al.
BRITISH JOURNAL OF CANCER (2009)
A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells
Ping Liu et al.
CANCER RESEARCH (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer
David P. Turner et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Zinc α2-glycoprotein:: A multidisciplinary protein
Md Imtaiyaz Hassan et al.
MOLECULAR CANCER RESEARCH (2008)
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer
Elahe A. Mostaghel et al.
CANCER RESEARCH (2007)
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu et al.
CANCER RESEARCH (2006)
Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system
Aurelien Descazeaud et al.
PROSTATE (2006)
Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas
G Alipov et al.
HISTOPATHOLOGY (2005)
Zinc-α2-glycoprotein, a lipid mobilizing factor, and is expressed and secreted by human (SGBS) adipocytes
Y Bao et al.
FEBS LETTERS (2005)
Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia
C Bing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Alterations of androgen receptor in prostate cancer
MJ Linja et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.
L Gaughan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
